Junliang Xu

Dr. Junliang Xu serves as Assistant Professor in the Department of Radiation Oncology at the University of Maryland, Baltimore, joining the institution in July 2020. He concurrently holds an associate faculty position with the University of Maryland Baltimore Graduate School for the medical physics certificate program since 2021.

His academic credentials include:

• Bachelor of Science in Theoretical Physics from University of Science & Technology of China (2006)
• PhD in Physics from Kansas State University (2012)
• Postdoctoral Researcher in Physics at The Ohio State University (2017)
• Medical Physics Residency at Fox Chase Cancer Center (2020)

Dr. Xu's research program bridges fundamental physics and clinical oncology, with primary focus on FLASH radiotherapy (ultra-high dose rate delivery), Linac-based stereotactic radiosurgery, precision irradiation techniques including single vocal cord treatment, dual-energy CT applications, and radiobiological mechanisms. His work integrates advanced physics methodologies to enhance radiation therapy precision while minimizing patient toxicity.

Publication analysis reveals a strategic evolution from foundational atomic/molecular physics (2012-2017) toward translational medical physics (2021-2023). Early work centered on ultrafast laser-matter interactions and electron diffraction imaging, while recent publications demonstrate applied expertise in FLASH-RT instrumentation, AI-driven treatment planning, and radiation safety protocols for novel delivery systems.

His contributions have garnered significant recognition:

• Nature Photonics highlight (2013) for molecular dynamics imaging
• U.S. Department of Energy feature (2012) for ultrafast imaging breakthrough
• Cover story in Laser Focus World (September 2013)
• Physical Review A Editors' Suggestion (2017) for field-ionization research

While student advisement details aren't specified, his dual appointment suggests involvement in graduate medical physics education. Current research appears focused on clinical implementation of FLASH radiotherapy and AI-enhanced treatment systems through hospital-based collaborations.

His laboratory work likely operates within the University of Maryland Medical Center's Radiation Oncology infrastructure, leveraging clinical linacs and imaging systems for translational research in high-precision radiation delivery.